Breast Cancer Research and Treatment

, Volume 90, Issue 2, pp 139–148 | Cite as

Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death

  • Eileen Rakovitch
  • Jean-Philippe Pignol
  • Carole Chartier
  • Michelle Ezer
  • Sunil Verma
  • George Dranitsaris
  • Mark Clemons

Abstract

Purpose. Complementary and alternative medicines (CAMS) are frequently used by patients with breast cancer and their use may be related to the presence of psychosocial distress. The objective of this study is to assess the presence of anxiety and depression in breast cancer patients who use CAM and assess how they perceive their risks of recurrence and dying from breast cancer compared to non-users.

Methods. Breast cancer patients attending ambulatory clinics at a single cancer center were approached by their oncologist. Participants completed a self-administered survey regarding CAM usage, beliefs associated with CAM, views of their risks of developing recurrent cancer, and of dying of breast cancer. The presence of anxiety and depression was scored using the Hospital Anxiety and Depression Scale (HADS). Responses were scored and compared between CAM users and non-users.

Results. A total of 251 patients completed the survey. CAM usage was reported by 43% of patients. Individuals who used CAM were younger [53.1 versus 63.0 year (p < 0.001)], had higher education (p < 0.001), were more likely to have full time employment [25.7 versus 16.3% (p < 0.001)] and have private insurance for medications (76 versus 60%, p=0.007) compared to non-users. CAM users perceived their risk of recurrence (p = 0.011) and death from breast cancer (p=0.0001) as being significantly greater than non-users. There were no significant differences in anxiety or depression scores between CAM and non-users.

Conclusion. CAM use is associated with an increased perception of breast cancer recurrence and of breast cancer-related death. There was no association between the presence of anxiety or depression and CAM use. Improved patient understanding of actual risks of recurrence and death are required such that women will be able to make more informed decisions about using CAMs.

Keywords

breast cancer complementary and alternative medicines perception of risk 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Boon, H, Stewart, M, Kennard, MA, Gray, R, Sawka, C, Brown, JB, McWilliam, C, Gavin, A, Baron, RA, Aaron, D, Haines-Kamka, T 2000Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptionsJ Clin Oncol1825152521PubMedGoogle Scholar
  2. 2.
    Burstein, HJ 2000Discussing complementary therapies with cancer patients: what should we be talking aboutJ Clin Oncol1825012504PubMedGoogle Scholar
  3. 3.
    Cassileth, BR 1999Complementary and alternative cancer medicineJ Clin Oncol174452[Review] [62 refs].PubMedGoogle Scholar
  4. 4.
    Richardson, MA, Sanders, T, Palmer, JL, Greisinger, A, Singletary, SE 2000Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncologyJ Clin Oncol1825052514PubMedGoogle Scholar
  5. 5.
    Malik, IA, Gopalan, S 2003Use of CAM results in delay in seeking medical advice for breast cancerEur J Epidemiol18817822PubMedGoogle Scholar
  6. 6.
    Sparreboom, A, Cox, MC, Acharya, MR, Figg, WD 2004Herbal remedies in the United States: potential adverse interactions with anticancer agentsJ Clin Oncol2224892503PubMedGoogle Scholar
  7. 7.
    Markowitz, JS, Donovan, JL, DeVane, CL, Taylor, RM, Ruan, Y, Wang, JS, Chavin, KD 2003Effect of St. John’s Wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.JAMA29015001504PubMedGoogle Scholar
  8. 8.
    Mathijssen, RH, Verweij, J, Bruijn, P, Loos, WJ, Sparreboom, A 2002Effects of St. John’s wort on irinotecan metabolism. J Nat Cancer Inst9412471249PubMedGoogle Scholar
  9. 9.
    Mansky, PJ, Straus, SE 2002St. John’s Wort: more implications for cancer patients. JNCI Cancer Spectrum9411871188Google Scholar
  10. 10.
    Burstein, HJ, Gelber, S, Guadagnoli, E, Weeks, JC 1999Use of alternative medicine by women with early-stage breast cancerNew Engl J Med34017331739PubMedGoogle Scholar
  11. 11.
    Ganz, PA, Desmond, KA, Leedham, B, Rowland, JH, Meyerowitz, BE, Belin, TR 2002Quality of life in long-term, disease-free survivors of breast cancer: a follow-up studyJNCI Cancer Spectrum943949Google Scholar
  12. 12.
    Mehta, P, Rodrigue, J, Nejame, C, Gaa, R, Wingard, JR 2000Acquiescence to adjunctive experimental therapies may relate to psychological distress: pilot data from a bone marrow transplant centerBone Marrow Transpl25673676Google Scholar
  13. 13.
    Rakovitch, E, Franssen, E, Kim, J, Ackerman, I, Pignol, JP, Paszat, L, Pritchard, KI, Ho, C, Redelmeier, DA 2003A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancerBreast Cancer Res Tr77285293[Report].Google Scholar
  14. 14.
    Zigmond, AS, Snaith, RP 1983The hospital anxiety and depression scaleActa Psychiat Scand67361370PubMedGoogle Scholar
  15. 15.
    DiGianni, LM, Garber, JE, Winer, EP 2002Complementary and alternative medicine use among women with breast cancer.J Clin Oncol2034S38SPubMedGoogle Scholar
  16. 16.
    Gertz, MA, Bauer, BA 2001Caring (really) for patients who use alternative therapies for cancerJ Clin Oncol1943464349PubMedGoogle Scholar
  17. 17.
    Creagan,  ET, Moertel, CG, O’Fallon, JR, Schutt, AJ, O’Connell, MJ, Rubin, J, Frytak, S 1979Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. New Engl J Med301687690CrossRefPubMedGoogle Scholar
  18. 18.
    Moertel, CG, Fleming, TR, Creagan, ET, Rubin, J, O’Connell, MJ, Ames, MM 1985High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. New Engl J Med312137141CrossRefPubMedGoogle Scholar
  19. 19.
    Black, WC, Nease, RFJ, Tosteson, AN 1995Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of ageJ Natl Cancer Inst87720731PubMedGoogle Scholar
  20. 20.
    Markman, M 2002Safety issues in using complementary and alternative medicine.J Clin Oncol2039S41SPubMedGoogle Scholar
  21. 21.
    D’Amico,  AV, Toupless, G, Lopes, L, Valentine, KJ, Cormack, RA, Tempany, CM, Kumar, S, Marks, PJ 2002Self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events.Int J Radia Oncol Biol Phys5413111313Google Scholar
  22. 22.
    Dunlap, N, Schwartz, GG, Eads, D, Cramer, SD, Sherk, AB, John, V, Koumenio, C 20031alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cellsBrit J Cancer89746753PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Eileen Rakovitch
    • 1
  • Jean-Philippe Pignol
    • 1
  • Carole Chartier
    • 1
  • Michelle Ezer
    • 1
  • Sunil Verma
    • 2
  • George Dranitsaris
    • 3
  • Mark Clemons
    • 2
  1. 1.Department of Radiation Oncology, Toronto-Sunnybrook Regional Cancer CentreSunnybrook and Women’s College Health Sciences CentreOntarioCanada
  2. 2.Division of Medical Oncology, Toronto-Sunnybrook Regional Cancer CentreSunnybrook and Women’s College Health Sciences CentreCanada
  3. 3.Department of Radiation Oncology, Cancer Care OntarioUniversity of TorontoCanada

Personalised recommendations